Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study

Breast Cancer Research

Zsuzsa Schaff²  Krisztina Bögi²  András Kiss²  László Szilák²  Pál Kaposi Novák²  Csilla Páska²  Ágnes Szik²  Sándor Paku¹  Janina Kulka²  Anna-Mária Tőkés² 

[1]Department of Molecular Pathology, Joint Research Organization of the Hungarian Academy of Sciences, Budapest, Hungary

[2]2nd Department of Pathology, Semmelweis University, Budapest, Hungary

关键词: tight junction;    real-time PCR;    immunohistochemistry;    claudin;    breast;   

Others  :  1114966
DOI  :  10.1186/bcr983

 received in 2004-01-23, accepted in 2004-12-02,  发布年份 2005

【 摘 要 】

Introduction

We compared levels of protein and mRNA expression of three members of the claudin (CLDN) family in malignant breast tumours and benign lesions.

Methods

Altogether, 56 sections from 52 surgically resected breast specimens were analyzed for CLDN1, CLDN3 and CLDN4 expression by immunohistochemistry. mRNA was also analyzed using real-time PCR in 17 of the 52 cases.

Results

CLDNs were rarely observed exclusively at tight junction structures. CLDN1 was present in the membrane of normal duct cells and in some of the cell membranes from ductal carcinoma in situ, and was frequently observed in eight out of nine areas of apocrine metaplasia, whereas invasive tumours were negative for CLDN1 or it was present in a scattered distribution among such tumour cells (in 36/39 malignant tumours). CLDN3 was present in 49 of the 56 sections and CLDN4 was present in all 56 tissue sections. However, CLDN4 was highly positive in normal epithelial cells and was decreased or absent in 17 out of 21 ductal carcinoma grade 1, in special types of breast carcinoma (mucinous, papillary, tubular) and in areas of apocrine metaplasia. CLDN1 mRNA was downregulated by 12-fold in the sample (tumour) group as compared with the control group using GAPDH as the reference gene. CLDN3 and CLDN4 mRNA exhibited no difference in expression between invasive tumours and surrounding tissue.

Conclusions

The significant loss of CLDN1 protein in breast cancer cells suggests that CLDN1 may play a role in invasion and metastasis. The loss of CLDN4 expression in areas of apocrine metaplasia and in the majority of grade 1 invasive carcinomas also suggests a particular role for this protein in mammary glandular cell differentiation and carcinogenesis.

【 授权许可】

   
2005 Tőkés et al., licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Gonzalez-Mariscal L, Avila Flores A, Betanzos A: The relationship between structure and function of tight junctions. In Tight Junctions. 2nd edition. Edited by Cereijido M, Anderson JM. Boca Raton, FL: CRC Press; 2001:89-119.
• [2]Gonzalez-Mariscal L, Betanzos A, Nava O, Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44.
• [3]Kawabe H, Nakanishi H, Asada M, Fukuhara A, Morimoto K, Takeuchi M, Takai Y: Pilt, a novel peripheral membrane protein at tight junctions in epithelial cells. J Biol Chem 2001, 276:48350-48355.
• [4]Katoh M, Katoh M: CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN family. Int J Mol Med 2003, 11:683-689.
• [5]Tsukita S, Furuse M: Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 1999, 9:268-273.
• [6]Hoevel T, Macek R, Mundigl O, Swisshelm K, Kubbies M: Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 2002, 191:60-68.
• [7]Kramer F, White K, Kubbies M, Swisshelm K, Weber BH: Genomic organisation of claudin 1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 2000, 107:249-256.
• [8]Furuse M, Sasaki H, Fujimoto K, Tsukita S: A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998, 143:391-401.
• [9]Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S: Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998, 141:1539-1550.
• [10]Gye MC: Expression of claudin-1 in mouse testis. Arch Androl 2003, 49:271-279.
• [11]Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y: Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 2000, 12:469-476.
• [12]Wang F, Daugherty B, Keisse LL, Wei Z, Foley JP, Savani RC, Koval M: Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol 2003, 29:62-70.
• [13]Inai T, Kobayashi J, Shibata Y: Claudin 1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999, 78:849-855.
• [14]Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033.
• [15]Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S: Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999, 147:195-204.
• [16]Hough CD, Shermann Baust CA, Pizer ES, Montz FJ, Im DD, Rosensheim NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287.
• [17]Van Itallie C, Rahner C, Anderson JM: Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 2001, 107:1319-1327.
• [18]Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 1991, 19:403-410.
• [19]Mannhalter C, Koizar D, Mitterbauer G: Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA. Clin Chem Lab Med 2000, 38:171-177.
• [20]Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res 2002, 30:e36.
• [21]Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20:1425-1431.
• [22]Mitic LL, Van Itallie CM, Anderson JM: Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000, 279:G250-G254.
• [23]Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S: Claudin based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002, 156:1099-1111.
• [24]Saitou M, Fujimoto K, Doi Y, Toh M, Fujimoto T, Furuse M, Takano H, Noda T, Tsukita S: Occludin deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 1998, 141:397-408.
• [25]Kubota K, Furuse M, Sasaki H, Sonoda N, Fujita K, Nagafuchi A, Tsukita S: Ca2+ independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr Biol 1999, 9:1035-1038.
• [26]Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ: Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 2003, 9:2567-2575.
• [27]Gregory M, Dufresne J, Hermo L, Cyr D: Claudin-1 is not restricted to tight junctions in the rat epididymis. Endocrinology 2001, 142:854-863.
• [28]Swisshelm K, Machl A, Planitzer S, Robertson R, Kubbies M, Hosier S: SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. Gene 1999, 226:285-295.
• [29]Polak-Charcon S, Ben-Shaul Y: Degradation of tight junctions in HT29, a human colon adenocarcinoma cell line. J Cell Sci 1979, 35:393-402.
• [30]Mullin JM, McGinn MT: The phorbol ester, TPA, increases transepithelial epidermal growth factor flux. FEBS Lett 1987, 221:359-364.
• [31]Mullin JM, Snock KV, Shurina RD, Noe J, George K, Misner L, Imaizumi S, O'Brien TG: Effects of acute vs. chronic phorbol ester exposure on transepithelial permeability and epithelial morphology. J Cell Physiol 1992, 152:35-47.
• [32]Rahner C, Mitic LL, Anderson JM: Heterogeneity in expression and subcellular localization of claudins 2, 3, 4 and 5 in the rat liver, pancreas and gut. Gastroenterology 2001, 120:411-422.
• [33]Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, et al.: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003, 63:6265-6271.